MBOT microbotmedical.com: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan Microbot Medical (MBOT)

The resilience of Microbot Medical Inc. (MBOT) is based on adherence to ESG principles and strict bioethics. The firm's EV/Sales multiple valuation demonstrates market expectations, where the -28785.71 level captures the current state. Updated calibration stands in sterile workshops support this stability. Growth potential relies on the future commercialization of microrobots for minimally invasive neurosurgical procedures.

microbotmedical.com (MBOT): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

MBOT (Microbot Medical, Inc): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:Microbot Medical Inc.
Produk sing diprodhuksi Microbot Medical Inc

Investors must evaluate the capitalization stability of Microbot Medical Inc. (MBOT) relative to its actual cash flows. For this endovascular surgery innovator, such analysis is critical due to the high cost of micro-robot development. This enterprise value-to-revenue ratio measures the overall business value, excluding the impact of debt load. An upward trend on this chart signals inflated market expectations, while a decline in the metric indicates that the company's assets are undervalued.

Analisis pesaing Microbot Medical Inc.

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|NAGE (ChromaDex Corp) - Nilai bisnis marang pendapatan|ZimVie Inc. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan angiodynamics.com (ANGO)|CERS - Rasio nilai perusahaan marang pendapatan|TKNO - Multiplikator EV/Sales|Monogram Technologies Inc (MGRM) - Rasio nilai perusahaan marang pendapatan|STSS - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan InfuSystem Holdings, Inc.|Multiplikator nilai perusahaan marang pendapatan Utah Medical Products UTMD|Multiplikator EV/Sales KRMD|Rasio total nilai perusahaan marang pendapatan Nyxoah, S.A.|Multiplikator EV/Sales PDEX (Pro-Dex Inc.)|Koefisien nilai perusahaan marang pendapatan ZTEK (Zentek Limited)|elutia.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Nilai perusahaan marang pendapatan|Retractable Technologies - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan harvardbioscience.com|Femasys Corp (FEMY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales MHUA|Predictive Oncology Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales CJMB (Callan JMB Inc)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales